Clinical Trial Update: Biobanking Upper Gastrointestinal Tumors to Evaluate Response (BURGER With BACON)

View source ↗

Summary

The BURGER With BACON trial (NCT06283238) evaluating biobanking of upper gastrointestinal tumors to evaluate response has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Snippet

Sponsor: Duke University | Conditions: GastroEsophageal Cancer | Status: WITHDRAWN